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The transcription factor Blimp-1 regulates the overall
accumulation of virus-specific CD8+ T cells during
acute viral infections. We found that increased prolif-
eration and survival of Blimp-1-deficient CD8+ T cells
resulted from sustained expression of CD25 and
CD27 and persistent cytokine responsiveness.
Silencing of Il2ra andCd27 reduced the Blimp-1-defi-
cient CD8+ T cell response. Genome-wide chromatin
immunoprecipitation (ChIP) sequencing analysis
identified Il2ra and Cd27 as direct targets of Blimp-
1. At the peak of the antiviral response, but not
earlier, Blimp-1 recruited the histone-modifying en-
zymes G9a and HDAC2 to the Il2ra and Cd27 loci,
thereby repressing expression of these genes. In
the absence of Blimp-1, Il2ra and Cd27 exhibited
enhanced histone H3 acetylation and reduced his-
tone H3K9 trimethylation. These data elucidate a
central mechanism by which Blimp-1 acts as an
epigenetic regulator and enhances the numbers of
short-lived effector cells while suppressing the
development of memory-precursor CD8+ T cells.
INTRODUCTION
In response to a virus infection, CD8+ T cells proliferate and
differentiate into effector cells that eradicate the pathogen.
Upon viral clearance, homeostasis is restored and a stable pop-
ulation of virus-specific memory CD8+ T cells remains to protect
against reinfection by that virus. The quality and quantity of the
CD8+ T cell response during the initial phase of the primary
response governs the frequency and function of long-lived
CD8+memory T cells (Obar and Lefranc¸ois, 2010). For an optimal
response, CD8+ T cells require at least three signals. These
include antigenic stimulation through the T cell receptor (TCR),
costimulation through receptors such as CD28, CD40, 4-1BB,
CD27, ICOS, and/or OX40, and cytokine stimulation via inflam-
matory cytokines (Duttagupta et al., 2009). The initial TCR
engagement triggers the upregulation of costimulatory mole-
cules and cytokine receptors, which are critical for the clonalexpansion and survival of the responding CD8+ T cells (Dutta-
gupta et al., 2009). However, this population of CD8+ T cells is
heterogeneous; themajority of effector cells die, whereas a small
population survive and become memory cells (Obar and Lefran-
c¸ois, 2010). Transcriptional profiling of effector and memory
CD8+ T cells in models of both acute and chronic virus infection
has recently provided insight into the distinct gene expression
programs characterizing distinct cell subsets (Doering et al.,
2012). Nonetheless, the precise mechanisms by which these
transcriptional programs are established and maintained during
CD8+ T cell differentiation remain largely unknown.
During the past decade, numerous studies have shown that
interleukin-2 (IL-2) plays an important role in regulating CD8+
T cell responses during the different stages of viral infection
(Boyman and Sprent, 2012). In vivo administration of IL-2 during
the early stages of the viral response is detrimental to the survival
of CD8+ T cells; however, IL-2 therapy during the contraction and
memory stages of the response promotes CD8+ T cell survival
(Blattman et al., 2003). Additional studies have indicated that
both primary and secondary CD8+ T cell responses are impaired
in the absence of IL-2 receptor signaling (Mitchell et al., 2010;
Williams et al., 2006). CD25, a subunit of the IL-2 receptor, is up-
regulated by IL-2 in conjunction with TCR stimulation (Boyman
and Sprent, 2012), and at early stages of the response to lym-
phocytic choriomeningitis virus (LCMV) infection, CD25 expres-
sion promotes the development of terminally differentiated
effector CD8+ T cells (Kalia et al., 2010). Nonetheless, the mech-
anism by which CD25 expression on CD8+ T cells is regulated
over the course of the immune response has not been described.
Members of the tumor necrosis factor (TNF) superfamily also
contribute to CD8+ T cell survival in vivo. CD27, a costimulatory
molecule in the TNF receptor family, binds to CD70 and pro-
motes CD8+ T cell proliferation (Duttagupta et al., 2009).
CD27-deficient mice have decreased primary and secondary
CD8+ T cell responses to influenza, and CD27 has been shown
to be important for the generation of long-term immunity to this
infection (Hendriks et al., 2000). CD27 signals also promote sur-
vival of activated CD8+ T cells by preventing Fas-dependent
apoptosis and by inducing the prosurvival factors Bcl2 and BclxL
(Dolfi et al., 2008; Peperzak et al., 2010a). A recent study has
shown that CD27-CD70 interactions induce IL-2 production
and thereby promote clonal expansion of primed CD8+ T cells
(Peperzak et al., 2010b). CD27 also marks CD8+ T cells with
memory potential (Hendriks et al., 2000; V.K. and R.M.W.,Immunity 39, 661–675, October 17, 2013 ª2013 Elsevier Inc. 661
Immunity
Epigenetic Modification by Blimp-1 in CD8+ T Cellsunpublished data). However, the mechanism by which CD27
expression on CD8+ T cells is regulated during the immune
response is not understood.
Blimp-1 is a transcription factor known to regulate the terminal
differentiation of numerous cell types (Martins and Calame,
2008). It drives the differentiation of CD8+ T cells toward the
short-lived effector fate, and the absence of Blimp-1 leads to
the development of memory-precursor CD8+ T cells that are
better at producing IL-2 (Kallies et al., 2009; Rutishauser et al.,
2009). Although Blimp-1 is known to regulate a number of target
genesmediating plasma cell differentiation (Martins andCalame,
2008), only a few targets of Blimp-1 in CD8+ T cells have been
identified. One recent study has shown that Blimp-1 directly reg-
ulates expression of the DNA-binding inhibitor Id3 and thereby
contributes to the development of short-lived effector T cells
(Ji et al., 2011). However, more global information on the targets
of Blimp-1 in CD8+ T cells is currently lacking.
In previously characterized systems, Blimp-1 has been shown
to mediate transcriptional repression by associating with his-
tone-modifying enzymes (Ancelin et al., 2006; Gyory et al.,
2004; Smith et al., 2011; Su et al., 2009; Yu et al., 2000). Because
there is differential histone modification between memory and
effector CD8+ T cell subsets (Araki et al., 2009), we considered
whether Blimp-1 might function in T cells to regulate histone
lysine modification. In osteosarcoma and B cell lymphoma cell
lines, Blimp-1 recruits the methyltransferase G9a and histone
deacetylases HDAC1 and HDAC2 to target genes, leading to
repressive modifications such as histone H3-K9 trimethylation
and H3 deacetylation, respectively (Gyory et al., 2004; Kubicek
et al., 2007; Yu et al., 2000). Whether any of these mechanisms
are involved in the Blimp-1-mediated regulation of CD8+ T cell
differentiation is not known.
We show here that CD25 and CD27 expression is dysregu-
lated in Prdm1/ T cells responding to LCMV infection, that
T cells expressing CD25 and CD27 preferentially survive during
acute viral infection, that sustained CD25 or CD27 expression
by retroviral transduction enhances T cell survival, and that
silencing of Il2ra and/or Cd27 in Blimp-1-deficient CD8+ T cells
decreases the magnitude of the virus-specific CD8+ T cell
response. Il2ra and Cd27 were identified as direct targets of
Blimp-1 with the use of deep-sequencing analysis of Blimp-1-
bound DNA targets in CD8+ T cells (chromatin immunoprecipita-
tion [ChIP] sequencing [ChIP-seq]). At the peak of CD8+ T cell
expansion, but not early in infection, we show that Blimp-1 binds
to regulatory regions of Il2ra and Cd27 and recruits G9a or
HDAC2 to promote repressive histone modifications at these
loci. These data provide key insights into the mechanism by
which Blimp-1 acts as an epigenetic regulator of target genes,
thereby dictating the fate of CD8+ effector T cells.
RESULTS
Blimp-1 Suppresses Cytokine Responsiveness of CD8+
T Cells at the Peak of the Antiviral Response
To investigate the role of Blimp-1 in regulating CD8+ T cell
responses during a virus infection, we used mice carrying a con-
ditional Prdm1 allele in which exon 5 is flanked by loxP sites (Ohi-
nata et al., 2005). This line was crossed to Cd4-cre+ transgenic
mice, thereby deleting Prdm1 in all ab T cells, and differed662 Immunity 39, 661–675, October 17, 2013 ª2013 Elsevier Inc.from those previously used in studies of Blimp-1 function in B
and T lymphocytes (Martins et al., 2006; Piskurich et al., 2000).
Hereafter, we refer to Prdm1flox/floxxCd4-cre+ mice as
‘‘Prdm1/ mice,’’ Prdm1flox/+xCd4-cre+ mice as ‘‘Prdm1+/
mice,’’ and CD4-cre+ littermate controls as ‘‘wild-type [WT]
mice.’’ We did not detect any changes in the proportion of lym-
phocytes in various lymphoid organs (Figure S1A, available on-
line), although naive Prdm1/ mice had a higher proportion of
CD44hiCD4+ and CD8+ T cells (Figure S1B), as previously re-
ported (Kallies et al., 2006; Martins et al., 2006).
Consistent with previous studies (Rutishauser et al., 2009;
Shin et al., 2009), there was a marked increase in both the num-
ber and the proportion of CD8+ T cells in Prdm1/mice at days
7 and 14 after LCMV-Armstrong infection (Figures 1A and 1B).
CD44hiCD8+ T cells and LCMV-specific CD8+ T cells showed
similar increases (Figure 1A). The amount of memory-precursor
effector CD8+ T cells (MPECs; KLRG1loIL-7Rhi; Joshi et al.,
2007) was also higher in Prdm1/ mice than in WT mice at
days 7 and 14 postinfection (Figure 1C), consistent with previous
data (Rutishauser et al., 2009). Deletion of Prdm1 in activated
CD8+ T cells from Prdm1/ mice was confirmed at days 7
and 14 after LCMV infection (Figure S1C). Viral clearance in the
spleen was normal in Prdm1/ mice (Figure S1D), indicating
that the increased magnitude of the CD8+ T cell response to
LCMV in Prdm1/mice was not due to impaired viral clearance.
As shown by decreased TUNEL reactivity (Figure 1D), we also
found that CD44hiCD8+ T cells from LCMV-infected Prdm1/
mice were less apoptotic than those fromWTmice at day 9 after
LCMV infection, in accord with increased expression of the pro-
survival factor Bcl2 at day 7 postinfection (Figure 1E). The tran-
scription factor eomesodermin (EOMES) promotes persistence
of memory CD8+ T cells (Banerjee et al., 2010). Consistent with
this, we found that more virus-specific CD8+ T cells from
Prdm1/ mice than from WT controls expressed EOMES at
days 7 and 14 postinfection (Figure S1E).
Next, we tested the hypothesis that differential expression of
cytokine receptors in WT versus Prdm1/ cells contributes to
altered T cell survival and/or proliferation. First, CD8+ T cells
were isolated from WT mice infected with LCMV Armstrong at
day 5 (early expansion), day 7 (peak expansion), and day 9
(contraction) postinfection, labeled with CFSE, and cultured
in vitro for 2 days with a panel of cytokines (Figure 1F). When
isolated at day 5 postinfection, CD8+ T cells spontaneously
proliferated in the absence of any cytokine; this response was
dramatically diminished by day 9 postinfection. In addition, cells
isolated at day 5 postinfection showed enhanced proliferation in
response to exogenous IL-12, as well as to the common g chain
(gc) family of cytokines, IL-2, IL-4 and IL-15. This response was
also attenuated by day 9 postinfection. In contrast, compared to
Prdm1+/ and WT T cells, Prdm1/ cells had a dramatically
enhanced proliferative response to the cytokines IL-2, IL-12,
and IL-15 at day 7 postinfection (Figure 1G).
Because the cytokine responsiveness of T cells during viral in-
fections can be regulated by themodulation of cytokine receptor
expression (Kalia et al., 2010; Sarkar et al., 2008), we further
examined the expression of CD25 (IL-2Ra), CD122 (IL-2Rb or
IL-15Rb), and CD124 (IL-4Ra) on CD8+ T cells at various time
points after LCMV infection. Consistent with the functional data
(Figure 1F), CD25 and CD122 protein and mRNA expression
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Figure 1. Sustained Cytokine Responsiveness in Prdm1–/– CD8+ T Cells after LCMV Infection
(A) The total number of CD8+ T cells and frequencies of CD8+CD44hi, GP33+CD8+, and NP396+CD8+ T cells at day 7 after LCMV infection are shown for WT and
Prdm1/ mice.
(B) The proportion of total CD8+ T cells in LCMV-infected WT and Prdm1/mice at days 7 and 14 postinfection is shown relative to that in uninfected mice (D0).
Histograms are representative of three independent experiments.
(C) NP396 tetramer-binding CD8+ T cells in WT and Prdm1/mice were analyzed for IL-7R and KLRG1 expression at days 7 and 14 after LCMV infection. The
numbers indicate the percentage of NP396 tetramer-binding CD8+ T cells in each subset. Data are representative of three independent experiments.
(D) Histograms show representative results of TUNEL staining in WT and Prdm1/CD44hiCD8+ T cells at day 9 after LCMV infection. The graph shows a
compilation of data from three independent experiments.
(E) NP396 tetramer-binding CD8+ T cells in WT and Prdm1/ mice were analyzed for intracellular Bcl2 expression at days 7 and 14 after LCMV infection. The
numbers indicate the percentage of Bcl2+ T cells in each sample. Data are representative of three independent experiments.
(F and G) CD8+ T cells were isolated from (F) WTmice at days 5, 7, and 9 after LCMV infection or from (G) WT, Prdm1+/, or Prdm1/mice at day 7 postinfection.
Cells were labeled with CFSE and cultured for 2 days with or without the indicated cytokines. Numbers indicate the percentage of divided cells. Histograms are
representative of three independent experiments.
See also Figure S1.
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through day 9 (Figures S1F and S1G). A similar pattern was
seen for Il12rb1 and Il12rb2, the transcripts encoding the sub-
units of the IL-12 receptor. In contrast, CD124 was expressed
in the naive CD8+ T cells, and both the protein and mRNA were
downregulated after LCMV infection, even at day 5 (Figures
S1F and S1G). Compared to WT control cells, Prdm1/ CD8+
T cells exhibited increased expression of Il2ra mRNA and, to a
lesser extent, Il12rb2 mRNA (Figure S1H). Overall, these datasuggest that decreased responsiveness to cytokines by WT
CD8+ T cells is due to cytokine receptor downregulation and
that Blimp-1 might function to suppress cytokine receptor
expression during the antiviral immune response.
Blimp-1 Regulates CD25 Expression in Virus-Specific
CD8+ T Cells during the Antiviral Immune Response
To test whether CD25 expression was dysregulated in CD8+
T cells lacking Blimp-1, we infected WT and Prdm1/ miceImmunity 39, 661–675, October 17, 2013 ª2013 Elsevier Inc. 663
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postinfection. At day 7, approximately twice as many Prdm1/
T cells as WT T cells expressed CD25 (Figures 2A and 2B). This
trend persisted through day 9 postinfection, although the overall
proportion of CD25+CD8+ T cells diminished dramatically after
day 7. This function of Blimp-1 was intrinsic to the CD8+
T cells, given that a similar difference in CD25 expression was
seen in P14 TCR transgenic WT or Prdm1flox/floxxGzmb-cre+
CD8+ T cells (in which Cre expression was under the control of
the human Granzyme B promoter [Rutishauser et al., 2009]) re-
sponding to LCMV after adoptive transfer into WT congenic
hosts (Figure 2C). To further confirm the inverse correlation
between Blimp-1 and CD25 expression, we infected Blimp-1-
GFP mice, in which GFP expression is under the control of
Prdm1 (Kallies et al., 2006). At days 7 and 9 postinfection, a
high proportion of CD44hiCD8+ T cells expressed Blimp-1;
further, there was an increased proportion of CD25+ cells in
the Blimp-1lo versus the Blimp-1hi subset (Figure 2D). These
data together indicate that Blimp-1 represses CD25 expression
at late stages during the antiviral CD8+ T cell response.
Recent studies have demonstrated that CD25 expression
during the early expansion phase of the antiviral CD8+ T cell
response is critical in regulating cell fate in that CD25hi cells
become short-lived effector cells (Kalia et al., 2010; Pipkin
et al., 2010). Consistent with these data, we also observed that
high CD25 expression at day 5 postinfection correlated with
decreased IL-7R and CD62L expression (Figure 2E); further, at
this stage of the response, cells expressing higher Blimp-1
also expressed more CD25 (Figure 2D) (Kalia et al., 2010). These
data indicate that strong IL-2R signaling during the early stage of
the antiviral CD8+ T cell response promotes the development of
short-lived effector cells. However, we considered whether the
role of IL-2R signaling might be different at the later stage of
the response, at which time CD8+ T cells undergo attrition. In
support of this possibility, we found that at day 9 postinfection,
CD25 expression on CD8+ T cells positively correlated with IL-
7R and CD62L expression (Figure 2E), indicating that compared
to the CD25lo population, theCD25hi population at this stagewas
enriched with memory-precursor cells. Based on KLRG1 and IL-
7R expression, analysis of virus-specific CD8+ T cells also
showed higher expression of CD25 on both KLRG1hiIL-7Rlo
and KLRG1loIL-7Rhi populations from the Prdm1/ mice than
on those from WT controls (Figures S2A and S2B).
To directly test whether differences in CD25 expression on
virus-specific CD8+ T cells are associated with differences in
T cell survival, we sorted CD25hi and CD25lo P14 TCR transgenic
CD8+ T cells from mice at day 7 after LCMV infection. Sorted
T cells were adoptively transferred into infection-matched con-
genic hosts, and the number of P14+ T cells was assessed at
day 15 postinfection (8 days posttransfer). We found that a
higher proportion and absolute number of virus-specific
CD25hiCD8+ T cells than of CD25lo transferred cells survived
(Figure 2F). These results indicate that, at day 7 postinfection,
CD25 expression on virus-specific CD8+ T cells correlated with
enhanced survival and/or persistence. To determine whether
enhanced proliferation contributed to this effect, we injected
LCMV-infected mice with bromodeoxyuridine (BrdU) at day 7
postinfection and analyzed virus-specific CD8+ T cells 12 hr
later. A higher proportion of CD25hi T cells than of CD25lo cells664 Immunity 39, 661–675, October 17, 2013 ª2013 Elsevier Inc.exhibited BrdU incorporation in WT and Prdm1/ mice (Fig-
ure S2C). Additionally, in response to ex vivo LCMV peptide
stimulation at day 8 postinfection, a higher proportion of
CD25hiCD8+ T cells than of CD25loCD8+ T cells produced inter-
feron-g (IFN-g) and IL-2 (Figure S2D), correlating high expression
of CD25 with a functional memory T cell response. These data
indicate that, following the peak of the CD8+ T cell response to
LCMV, higher expression of CD25 correlates with enhanced sur-
vival of virus-specific T cells.
Blimp-1 Regulates CD27 Expression in Virus-Specific
CD8+ T Cells
CD27 is a costimulatory molecule that promotes CD8+ T cell pro-
liferation and memory generation (Duttagupta et al., 2009; Hen-
driks et al., 2000). To test whether CD27 expression in CD8+
T cells is regulated by Blimp-1, we examined T cells from
LCMV-infected WT and Prdm1/ mice. At day 9 postinfection,
there was a higher proportion of CD27+ virus-specific CD8+
T cells in the Prdm1/ mice than in the controls (Figure 3A),
consistent with previous reports (Kallies et al., 2009; Rutishauser
et al., 2009). This difference was visible at day 7.5 postinfection
but increased in magnitude at days 8 and 9 (Figure 3B). As was
the case for CD25 expression (Figure 2C), altered CD27 expres-
sion was due to a CD8+-T-cell-intrinsic role for Blimp-1 (Fig-
ure 3C) and was observed in both KLRG1hiIL-7Rlo and
KLRG1loIL-7Rhi populations (Figures S3A and S3B). As a further
correlation, we examined CD8+ T cells in LCMV-infected Blimp-
1-GFP mice. At day 9 postinfection, Blimp-1hi cells expressed
less CD27 than did Blimp-1lo cells (Figure 3D).
A previous study showed that CD27-expressing CD8+ T cells
represent a functional memory cell pool (Hikono et al., 2007).
In order to test whether the CD27+CD8+ T cells present at day
9 after LCMV infection represent a subset enriched with mem-
ory-precursor cells, we examined IL-7R expression on cells
with varying CD27 expression and found that increasing
amounts of IL-7R correlated with increased CD27 expression
(Figure 3E).
Virus-specific P14 CD27hi and CD27loCD8+ T cells were next
sorted from mice at day 9 after LCMV infection and were adop-
tively transferred into infection-matched hosts. When analyzed
7 days later (day 16 postinfection), there was a higher proportion
and absolute number of P14 CD8+T cells from the CD27hi subset
than of cells from the CD27lo subset (Figure 3F). These data
together indicate that Blimp-1 normally represses CD27 expres-
sion at late stages of the antiviral CD8+ T cell response and
thereby contributes to the attrition of effector cells after virus
clearance.
CD25 and CD27 Expression Enhances the Survival of
CD8+ T Cells
To test whether persistent CD25 or CD27 expression has a
functional role in promoting CD8+ T cell survival during an anti-
viral immune response, we used retroviral gene transfer to
constitutively express CD25 or CD27 in LCMV-specific T cells.
P14 TCR transgenic CD8+ T cells were stimulated in vitro with
LCMV-GP33 peptide, infected with retroviruses, and then trans-
ferred into LCMV-infected (day 1 postinfection) recipient mice
(Figure 4A). Expression of hCD2 indicated that there was a
similar transduction efficiency for each of the retroviral (RV)
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Figure 2. Increased CD25 Expression in Prdm1–/– CD8+ T Cells during the Antiviral Immune Response
(A and B) CD8+ T cells fromWT and Prdm1/mice were isolated at days 7–9 after LCMV infection and stained with CD25 antibodies plus GP33 or NP396 LCMV-
specific tetramers. CD25 expression on tetramer-positive CD8+ T cells is shown (A) along with a compilation of data from three independent experiments (B). All
error bars represent the SEM.
(C) P14 TCR transgenic CD90.1+Prdm1flox/floxxGzmb-cre+ or CD90.1+Prdm1flox/floxxGzmb-cre (WT) littermate splenocytes were adoptively transferred into
CD90.2+ congenic WT mice, and infection with LCMV followed. At day 9 postinfection, CD90.1+CD8+ T cells were analyzed for CD25 expression (left panels). On
the right, the percentages of CD25+CD90.1+CD8+ T cells from two independent experiments each with four to five mice are shown.
(D) Blimp-1-GFP reporter mice were infected with LCMV, and CD44hiCD8+ T cells were analyzed at days 5, 7, and 9 postinfection for GFP expression (left panels).
On the right, Blimp-1lo and Blimp-1hi populations were analyzed for CD25 expression. The percentages ± SEM of CD25+ cells are indicated on each plot. Data are
representative of two independent experiments.
(E)WTmice were infectedwith LCMV, andCD44hiCD8+ T cells were analyzed on days 5 and 9 postinfection for CD25 expression (left panels). On the right, CD25lo
and CD25hi populations were analyzed for IL-7R and CD62L expression. The percentages of positive cells are indicated on each plot. Data are representative of
four independent experiments.
(F) P14 TCR transgenic CD45.1+ splenocytes were adoptively transferred into CD45.2+ congenic WT mice, and infection with LCMV followed. At day 7 post-
infection, 13 106 CD25loP14+CD45.1+CD8+ or CD25hiP14+CD45.1+CD8+ T cells were isolated by cell sorting and adoptively transferred into infection-matched
CD45.2+ recipient mice. Eight days later, P14+ cells were assessed. Data shown include a compilation of two independent experiments and representative flow
cytometry analysis.
See also Figure S2.
Immunity
Epigenetic Modification by Blimp-1 in CD8+ T Cells
Immunity 39, 661–675, October 17, 2013 ª2013 Elsevier Inc. 665
A B C
D
E
F
Prdm1-/-xGzmb-cre+ 
Prdm1-/-xGzmb-cre+ 
Prdm1-/-xGzmb-cre+ 
Figure 3. Increased CD27 Expression in Prdm1–/– CD8+ T Cells during the Antiviral Immune Response
(A andB)CD8+ T cells fromWT andPrdm1/micewere isolated at day 9 after LCMV infection and stainedwithCD27antibodies plusGP33orNP396 LCMV-specific
tetramers.CD27expressionontetramer-positiveCD8+Tcells isshown (A)alongwithacompilationofdata fromthreeexperiments (B).All errorbars represent theSEM.
(C) P14 TCR transgenic CD90.1+Prdm1flox/floxxGzmb-cre+ or CD90.1+Prdm1flox/floxxGzmb-cre (WT) littermate splenocytes were adoptively transferred into
CD90.2+WTmice, and infection with LCMV followed. At day 9 postinfection, CD90.1+CD8+ T cells were analyzed for CD27 expression (left panels). On the right, a
compilation of data from two independent experiments each with four to five mice is shown.
(D) Blimp-1-GFP reporter mice were infected with LCMV, and CD44hiCD8+T cells were analyzed at day 9 postinfection for GFP expression (top panel). Below,
Blimp-1lo and Blimp-1hi populations were analyzed for CD27 expression. The percentages of CD27-positive cells and the mean fluorescence intensity of CD27
expression are indicated on each histogram. Data are representative of two independent experiments.
(E) WT mice were infected with LCMV, and CD44hiCD8+ T cells were analyzed on day 9 postinfection for CD27 expression (left panel). On the right, CD27lo (R1),
CD27int (R2), and CD27hi (R3) populations were analyzed for IL-7R expression. The percentages of IL-7R-positive cells are indicated on each histogram. Data are
representative of four independent experiments.
(F) P14 TCR transgenic CD45.1+ splenocytes were adoptively transferred into CD45.2+ WT mice, and infection with LCMV followed. At day 9 postinfection, 1 3
106 CD27loP14+CD45.1+CD8+ or CD27hiP14+CD45.1+CD8+ T cells were isolated by cell sorting and were adoptively transferred into infection-matched CD45.2+
recipient mice. Seven days later, the absolute numbers and percentages of P14+ cells were determined. Data shown include a compilation of two independent
experiments and representative flow cytometry analysis.
See also Figure S3.
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transduction led to increased CD25 or CD27 expression (Fig-
ure 4B). When analyzed at days 8, 11, and 14 postinfection,
LCMV-specific P14+ cells expressing either CD25 or CD27
were increased in proportion relative to cells transduced with
the empty RV (mock RV; Figures 4C and 4D). These results indi-
cate that persistent CD25 and CD27 expression promotes
enhanced expansion of T cells rather than effecting contraction
and thereby leads to increased survival of CD8+ T cells.
To address whether CD25 or CD27 expression accounts for
the enhanced survival of Prdm1/CD8+ T cells during an anti-
viral immune response, we utilized small hairpin RNA (shRNA)
silencing to diminish expression of these proteins in LCMV-spe-
cific Prdm1/ T cells. For these experiments, adoptively trans-
ferred P14+CD90.1+Prdm1flox/floxxGzmb-cre+ splenocytes were
activated in vivo by infection of recipient mice with LCMV. At
day 5 postinfection, P14+ T cells were isolated by cell sorting,
stimulated in vitro with CD3 and CD28 antibodies for 24 hr, in-
fected with retroviruses, and then transferred into LCMV-in-
fected (day 6 postinfection) recipient mice (Figure 4E). As shown,
we achieved similar transduction efficiencies for each of the RV
constructs (Figure 4F); in addition, each shRNA was able to
reduce expression of the targeted gene (Figure 4G). When
analyzed at day 9 postinfection, the proportion of Prdm1/
CD8+ T cells transduced with shCD25 or shCD27 was lower
than that of cells transduced with the scrambled shRNA control
(Figures 4G and 4H). Moreover, silencing of both Il2ra and Cd27
further decreased the frequency of GFP+CD8+ T cells (Figures
4G and 4H). These results indicate that the increased magnitude
and survival of CD8+ T cells in Prdm1/mice was in part due to
sustained expression of CD25 and CD27.
Genome-wide ChIP-Seq Analysis Identifies Il2ra and
Cd27 as Direct Targets of Blimp-1 in CD8+ T Cells
Transcriptional regulation by Blimp-1 has been extensively stud-
ied in B cells, leading to the identification of Myc, Pax5, Bcl6,
Ciita, Spib, Id3, and Prdm1 as direct Blimp-1 target genes (Mar-
tins and Calame, 2008). Substantially less is known about the
direct targets of Blimp-1 in T cells, particularly CD8+ T cells. To
address whether Il2ra or Cd27 might be a direct target of
Blimp-1, we performed genome-wide ChIP-seq analysis. Naive
CD8+ T cells from OT-I TCR transgenic Rag1/mice were stim-
ulated for 3 days in vitro in the presence of IL-2 to upregulate
Blimp-1 (Gong and Malek, 2007) (Figure 5A). For identifying the
genomic locations of Blimp-1 binding sites, chromatin was
immunoprecipitated with Blimp-1 antibody and DNA was sub-
jected to deep sequencing. The majority of sites identified
were located within introns or in regions distal to a gene (49%
or 29%, respectively); a minority of binding sites was found in
promoter regions (Figure 5B). Using the Ingenuity pathway data-
base, we classified 10,847 Blimp-1 target genes and found that
the majority of known genes were in the groups encoding en-
zymes, transcriptional regulators, transporters, and kinases (Fig-
ure S4). To address the functional importance of specific Blimp-1
target genes in CD8+ T cells, we chose to focus on cytokine and
other transmembrane receptors (Figure 5C and Table S1)
because these are known to be critical in regulating T cell func-
tion and differentiation. Consistent with previous studies (Ji et al.,
2011; Rutishauser et al., 2009), this analysis identified Prdm1,Id3, Bcl6, Pax5, Myc, and Ciita as having Blimp-1 binding sites
in CD8+ T cells (Figure 5D). In addition, we identified Il2ra,
Cd27, Il2rb, Sell (Cd62l), Eomes, and Ccr6 as Blimp-1 targets
(Figure 5E). In CD4+ T cells, Il2 is a downstream target of
Blimp-1 (Martins et al., 2008); however, we did not detect
Blimp-1 binding to the Il2 locus in CD8+ T cells.
The ChIP-seq analysis identified Blimp-1 binding sites in the
first intron of Il2ra and at two distal sites within 10 kb of the
Cd27 transcription start site (Figure 5E). When using activated
cells from LCMV-infected mice at day 7 postinfection, we found
that Blimp-1 bound to the Il2ra and Cd27 loci in WT CD8+ T cells
(Figure 5F). As expected, there was no binding of Blimp-1 to any
of these sites in Prdm1/CD8+ T cells, nor was Blimp-1 binding
detected at nonspecific regions (Amp2 in Il2ra and Amp3 in
Cd27). These data support the conclusion that Blimp-1 binding
to the Il2ra and Cd27 loci represses expression of CD25 and
CD27, respectively, during the antiviral CD8+ T cell response.
Blimp-1 Is Associated with Histone-Modifying Enzymes
G9a and HDAC2 in CD8+ T Cells
To address the mechanism by which Blimp-1 mediates tran-
scriptional repression in primary CD8+ T cells, we first performed
coimmunoprecipitation assays on T cells activated in vitro. Given
that Blimp-1 expression in T lymphocytes requires a combina-
tion of TCR plus cytokine stimulation (Gong and Malek, 2007),
we compared cells activated through the TCR for 3 days in the
presence or absence of a cytokine cocktail containing IL-2,
IL-4, and IL-12. Blimp-1 was then immunoprecipitated, and
potential binding partners were identified by immunoblotting
with antibodies to the histone methyltransferases, G9a or
EZH2, or to the histone acetyltransferases, HDAC1 or HDAC2.
As shown in Figure 6A, Blimp-1 associated with G9a and
HDAC2, but not with HDAC1 or EZH2. Similarly, immunoprecip-
itates of HDAC2 or G9a coprecipitated Blimp-1, but interestingly,
G9a was not associated with HDAC2, indicating that the Blimp-
1-HDAC2 and the Blimp-1-G9a complexes are distinct. To
confirm these interactions in a more physiological setting, we
performed a single-cell-based proximity ligation assay. This
assay reveals protein-protein interactions when two protein-
antibody complexes are in sufficiently close proximity. Interac-
tions between Blimp-1 and G9a, Blimp-1 and HDAC2, or
Blimp-1 and EZH2 were analyzed in situ in activated CD8+
T cells by intracellular labeling with each antibody (Figure 6B).
These data demonstrate that Blimp-1 and G9a, or Blimp-1 and
HDAC2, are within 16 nm of each other in intact nuclei of acti-
vated CD8+ T cells, thereby supporting a role for Blimp-1 in re-
cruiting these repressive chromatin-modifying enzymes to
Blimp-1 target genes in CD8+ T cells.
Blimp-1 Promotes Repressive Chromatin Modifications
by Recruiting Histone-Modifying Enzymes to Target
Genes
To examine whether Blimp-1 mediates the recruitment of his-
tone-modifying enzymes G9a or HDAC2 to Blimp-1 binding
sites, we isolated CD8+ T cells from WT or Prdm1/ mice at
day 7 after LCMV infection. ChIP assays revealed that both
G9a and HDAC2 were present at the Il2ra and Cd27 loci in WT
CD8+ T cells at day 7 postinfection (Figures 7A and 7B). We
did not detect binding of G9a or HDAC2 to any of these sitesImmunity 39, 661–675, October 17, 2013 ª2013 Elsevier Inc. 667
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the recruitment of G9a and HDAC2 to these genes. To determine
whether Blimp-1 forms a complex with either G9a or HDAC2 at
these loci, we performed sequential ChIP assays (ChIP-reChIP)
with CD8+ T cells from WT or Prdm1/ mice at day 7 after
LCMV infection. First, a primary ChIP with Blimp-1 antibody
was performed; after elution of these complexes from the pri-
mary antibody, secondary immunoprecipitations with G9a or
HDAC2 antibody were performed (Figure 7C). These data indi-
cated that Blimp-1 is in close proximity to G9a and HDAC2 on
the Il2ra locus. On Cd27, Blimp-1 was tightly associated with
HDAC2, but association with G9a was weaker at the distal site
and absent from the proximal region. Together, these findings
provide evidence that Blimp-1 recruits G9a and HDAC2 to target
genes in primary T cells activated in vivo.
To determine whether this recruitment is associated with
changes in histone modifications at these loci, we examined
histone H3 acetylation (H3Ac) and methylation on Il2ra and
Cd27 by ChIP. H3Ac and histone H3 trimethylation on lysine 4
(H3K4me3) are indicative of permissive chromatin states, given
that they correlate with gene expression (Weng et al., 2012). In
contrast, histone H3 methylation on lysine 9 (H3K9me2 or
H3K9me3) and on lysine 27 (H3K27me3) mark repressive chro-
matin states that correlate with gene silencing (Kouzarides,
2007). Compared to CD8+ T cells from WT control mice, CD8+
T cells isolated from Prdm1/ mice at day 7 after LCMV infec-
tion had increased amounts of H3Ac and H3K4me3 and reduced
amounts of H3K9me2, H3K9me3, and H3K27me3 at the Il2ra
locus (Figure 7D). Analysis of the Cd27 locus revealed that
compared to WT cells, Prdm1/CD8+ T cells also showed an
increase in permissive modifications and a reduction in repres-
sive modifications, although these correlations were not uni-
formly observed at both of the regions analyzed (Figure 7E).
Overall, these chromatin states correlated with the increased
CD25 and CD27 expression seen in Prdm1/ versus WT
CD8+ T cells from LCMV-infected mice.
At day 5 postinfection, Blimp-1 and CD25 were highly ex-
pressed, and unlike at day 9 postinfection, their expression
levels positively correlated with each other (Figure 2D and Fig-
ure 7F). ChIP analysis of the Il2ra locus in CD25hiCD8+ T cells iso-
lated at day 5 after LCMV infection showed high amounts of
H3Ac in the absence of repressive modifications, along with an
absence of Blimp-1, G9a, or HDAC2 binding (Figure 7G).
Blimp-1 binding was still detected at one site on Cd27 at day 5Figure 4. Sustained CD25 and CD27 Expression Extends the Survival o
(A) Splenocytes from P14 TCR transgenic mice were stimulated with GP33 peptid
an empty virus (mock RV) as a negative control. A total of 2 3 105 splenocytes w
splenocytes from infected recipient mice were analyzed on days 8, 11, and 14 p
(B) A subset of transduced splenocytes was cultured in vitro for 2 days, and the tr
right, enforced CD25 or CD27 expression on hCD2+ cells was assessed.
(C and D) Representative plots (C) and a compilation of data (D) from two indepe
infection in recipient mice receiving cells transduced with the indicated retroviru
(E) P14 TCR transgenic CD90.1+Prdm1flox/floxxGzmb-cre+ splenocytes were adop
day 5 postinfection, CD90.1+CD8+ T cells isolated by cell sorting were stimulate
pressing shRNAs to silencing Il2ra (shCD25), Cd27 (shCD27), shCD25, and shC
adoptively transferred into day 6 infection-matched CD90.2+ recipient mice.
(F) A subset of transduced CD90.1+CD8+ T cells was cultured in vitro for 2 days,
(G and H) Three days after transfer, the percentages ± SEM of GFP+CD90.1+CD
panel), and a compilation of data from three independent experiments is shown a
GFP+CD90.1+CD8+ cells, along with the percentages ± SEM from three compilepostinfection, but in this case, Blimp-1 binding was not sufficient
to recruit G9a or HDAC2 (Figure 7H), consistent with the lack of
repressive modifications and high amounts of H3Ac at this locus
(Figure 7I). Together, these findings demonstrate that Blimp-1
induces a repressive chromatin state at Il2ra and Cd27 in CD8+
T cells at the peak of the response to LCMV infection, but not
at earlier stages.
DISCUSSION
Prdm1/CD8+ T cells have an enhanced capacity to differen-
tiate into memory cells (Kallies et al., 2009; Rutishauser et al.,
2009). In this report, we have identified an important mechanism
by which Blimp-1 association with histone-modifying enzymes
suppresses Il2ra and Cd27 expression to regulate the overall
magnitude of the virus-specific memory CD8+ T cell response.
Upon virus infection and T cell activation, costimulatory signals,
alongwith the inflammatory cytokinemilieu, are key components
leading to the generation of CD8+ effector and memory-precur-
sor T cells that together promote virus clearance and provide
long-term protection against reinfection. After virus clearance,
CD8+ T cells downregulate costimulatory receptor and cytokine
receptor expression (Dolfi et al., 2008; Kalia et al., 2010). After
this process, the vast majority of the virus-specific effector
population undergoes apoptosis (Razvi et al., 1995), most likely
as a result of cytokine deprivation and the lack of costimulatory
signals. Our data indicate that CD25 (or CD27) has an impact on
the small proportion of effector cells capable of long-term
survival and provides an important signal to promote the survival
of cells expressing the receptor in this specific subset. We
propose that Blimp-1 normally functions to downregulate cyto-
kine receptor expression and thereby promotes the death of
effector T cells. This mechanism would function in addition to
the regulation of proliferation and survival genes by Blimp-1, as
proposed previously (Martins et al., 2008).
Over the past decade, numerous studies have investigated the
role of IL-2 signaling in CD8+ T cell activation and differentiation
in response to virus infections (Boyman and Sprent, 2012). These
studies showed that CD25 expression and the strength of IL-2R
signaling during T cell priming influences the relative generation
of effector versus memory CD8+ T cells. Furthermore, in vivo
administration of IL-2 or IL-15 during T cell contraction increases
the size of the CD8+ memory pool. These data prompted us to
investigate whether IL-2 receptor expression is regulated byf CD8+ T Cells
e for 1 day and then transduced with retroviruses expressing CD25 or CD27 or
ere adoptively transferred into recipient mice 1 day after LCMV infection, and
ostinfection.
ansduction efficiency was assessed by staining for human CD2 (hCD2). On the
ndent experiments show hCD2+ CD8+ T cells at days 8, 11, and 14 after LCMV
s.
tively transferred into CD90.2+ WT mice, and infection with LCMV followed. At
d with aCD3 and aCD28 for 24 hr and then transduced with retroviruses ex-
D27 or scrambled as a negative control. Retrovirally transduced cells were
and the transduction efficiency was assessed by GFP fluorescence.
8+ cells were determined; dot plots show a representative experiment (G, top
s a scatter plot (H). A representative example of CD25 and CD27 expression on
d independent experiments, is shown (G, lower panels).
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Figure 5. Genome-wide Identification of Blimp-1 Binding Sites in CD8+ T Cells
(A) Naive CD8+ T cells isolated fromOT-I+Rag1/mice were stimulated with plate-bound aCD3 and aCD28 and IL-2 (50ng/ml) for 3 days, and Blimp-1 ChIP-seq
followed.
(B) Frequency (pie chart) of Blimp-1 binding sites localized to each region of target genes in the mouse genome (mm9). Abbreviations are as follows: TSS,
transcription start site; and TES, transcription end site.
(C) Functional grouping of genes related to secreted proteins and their cognate receptors with Blimp-1 binding sites within 10 kb of the transcription start site.
(D and E) Identification of Blimp-1 binding sites on known (D) and unknown (E) target genes. The scale bars indicate the relative kb scale on each gene, and the
numbers on the right display themagnitude of sequence enrichment on a log2 scale. Peakswere identifiedwith Cisgenome 2.0, and all enrichment data on Blimp-
1 binding sites are shown in the ChIP-seq tracks.
(F) WT and Prdm1/mice were infected with LCMV, and CD44hiCD8+ T cells were isolated at day 7 postinfection. As a control, naive CD8+ T cells were isolated
from uninfected mice (D0). ChIP assays were performed with antibodies to Blimp-1 or mouse immunoglobulin G (IgG) (ISO). Each ChIP eluate was amplified by
quantitative PCR (qPCR) for the indicated regions of Il2ra (PCR amplicons 1 and 2; left two panels) or Cd27 (PCR amplicons 1, 2, and 3; right three panels).
Amplicon 2 of Il2ra and amplicon 3 ofCd27 indicate nonspecific regions where Blimp-1 binding was not detected by ChIP-seq. Data shown include a compilation
of three independent experiments, and error bars represent the SEM.
See also Figure S4 and Table S1.
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Figure 6. Blimp-1 Recruits G9a and HDAC2 in Activated CD8+ T Cells
(A) WTCD8+ T cells were stimulated in vitro with aCD3 and aCD28 for 2 days with (+) or without () a cocktail of cytokines containing IL-2, IL-4, and IL-12. Lysates
were immunoprecipitated with aBlimp-1 (left top panels, right top panel, and middle panel), aHDAC2 (left bottom panels), or aG9a (right bottom panels) anti-
bodies. Immunoblotting (IB) with the indicated antibodies followed. Data are representative of three independent experiments. The following abbreviation is used:
WCL, whole-cell lysate.
(B) Stimulated CD8+ T cells were stained with (1) aHDAC2 and either a mouse IgG control (ISO) or aBlimp-1 (left upper panels), (2) aG9a and a mouse IgG control
or aBlimp-1 (right upper panels), or (3) aEZH2 and amouse IgG control or aBlimp-1 (left lower panels), and the Duolink proximity ligation assay followed. Samples
were counterstained for nuclei (blue; DAPI). Yellow signals demonstrate close proximity of the two proteins. The graph (lower right panel) is a compilation of data
from three independent experiments, and error bars represent the SEM.
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Figure 7. Blimp-1 Regulates Histone Modifications at the Il2ra and Cd27 Loci in CD8+ T Cells at Day 7 after LCMV Infection
(A and B) WT and Prdm1/mice were infected with LCMV, and CD44hiCD8+ T cells were isolated at day 7 postinfection. As a control, naive CD8+ T cells were
isolated from uninfected mice (D0). ChIP assays were performed with antibodies to G9a or HDAC2. Each ChIP eluate was amplified by qPCR for the indicated
(legend continued on next page)
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response, and further, whether the function of IL-2R signaling
might also vary between T cell priming and T cell contraction.
CD25 expression on CD8+ T cells is rapidly induced during the
early stage of viral infection, mediated by a combination of
TCR and IL-2R signaling (Boyman and Sprent, 2012). During
this early stage, cells expressing CD25 are destined to be
short-lived effectors, in keeping with their high Blimp-1 expres-
sion (Kalia et al., 2010; Rutishauser et al., 2009). Our data indi-
cate that, at this time point, Blimp-1 expression is not able to
override the positive signals promoting CD25 expression. In
contrast, by day 7 postinfection, CD25 expression is nearly
absent on virus-specific cells, a change that is Blimp-1 depen-
dent. We propose that after viral clearance and the cessation
of IL-2 production, CD25 expression becomes susceptible to
regulation by Blimp-1. It has been shown previously that
Prdm1/ mice consistently maintain higher proportions and
numbers of memory CD8+ T cells (Rutishauser et al., 2009).
Although we have not directly looked at later time points after
viral infection, the transcription factor EOMES was upregulated
in Prdm1/ mice, consistent with our ChIP-seq analysis.
Prdm1/ mice were also more responsive to IL-15 stimulation.
Therefore, it is likely that the EOMES and IL-15 axis promotes the
homeostatic proliferation and survival of the increased memory
T cell pool in Prdm1/ mice.
Here, we confirmed that CD25 and CD27 expression was
significantly altered in Prdm1/ CD8+ T cells during the course
of LCMV infection. Blimp-1 directly bound to the Il2ra locus, was
required for recruitment of HDAC2 andG9a to this gene, andwas
required for the repressive chromatin modifications seen at the
Il2ra locus in CD8+ T cells from day 7 LCMV-infected mice. The
transcriptional regulation of Il2ra in response to TCR stimulation
plus IL-2 has been well studied (Malek, 2008). Several transcrip-
tion factors orchestrate this response, and four major regulatory
regions have been identified (Kim et al., 2001; Malek, 2008). The
first intron of the gene contains binding sites for signal trans-
ducer and activator of transcription 5a (STAT5a), STAT5b, and
high-mobility group protein 1 (HMG-I(Y)), and binding of these
factors occurs in response to IL-2 (Kim et al., 2001). Interestingly,
it is this region that also contains the Blimp-1 binding site identi-
fied in our ChIP-seq analysis and verified by our Blimp-1 ChIP
assays, further supporting a model in which Blimp-1-mediated
repression of Il2ra is antagonistic to the positive signals upregu-
lating Il2ra transcription.region (PCR amplicon1) of Il2ra (A) or for each of two regions (PCR amplicon1 and
experiments.
(C) ChIP eluates from aBlimp-1 immunoprecipitates were reprecipitated with aG
eluates were amplified by qPCR for the indicated regions of Il2ra and Cd27. Dat
(D and E) WT and Prdm1/ mice were infected with LCMV, and CD44hiCD8+
antibodies tomodified histone H3 as indicated. ChIP eluates were amplified by qP
H3K4me3) and three repressive (dimethylated lysine 9 [H3Krme2], trimethylated
histone H3 were analyzed. Data shown include a compilation of three independe
(F) The mRNA expression of Il2ra and Prdm1 in CD25hiCD44hiCD8+ or CD25loCD4
PCR. Data shown include a compilation of three independent experiments.
(G–I) CD25hiCD44hiCD8+ T cells or CD27hiCD44hiCD8+ T cells were sorted at day
HDAC2, or control IgG andwith antibodies tomodified histone H3 as indicated. Fo
control IgG on CD44hiCD8+ T cells sorted at day 7 postinfection (G and H; D7*). Ea
Cd27 (H and I). Each graph is a compilation of data from three independent exp
The following abbreviation is used: ISO, isotype control antibody.Unlike that of Il2ra, the transcriptional regulation ofCd27 is not
well defined in T cells. Although present on naive T cells, TCR
stimulation leads to further upregulation of CD27 (de Jong
et al., 1991). The mechanisms leading to CD27 downregulation
are even more poorly characterized. Although ligation with
CD70 or stimulation with phorbol myrsitate acetate downregu-
lates CD27 expression (Hintzen et al., 1994; Nolte et al., 2005),
the factors mediating this event are not known. Our work has
provided evidence that Blimp-1 plays a key role in CD27 down-
regulation following the peak of the antiviral CD8+ T cell
response. As with the Il2ra locus, Blimp-1 binds to Cd27 and
recruits the histone-modifying enzymes, HDAC2 and G9a, lead-
ing to repressive modifications at this locus during CD8+ T cell
contraction.
The histone-modifying enzyme G9a has recently been a topic
of investigation in lymphocytes (Thomas et al., 2008). Although
the development of lymphocytes in G9a-deficient mice was
found to be normal, amounts of H3K9me2 were greatly reduced
and led to aberrantly low usage of Igl L chains in B cells (Thomas
et al., 2008); in addition, G9a has been shown to regulate
H3K9me3 in vivo (Collins and Cheng, 2010). More recently,
G9a-deficient CD4+ T cells were shown to be impaired in cyto-
kine production associated with T helper 2 cells and exhibited
increased IL-17A and IFN-g production, demonstrating that
G9a regulates genes involved in lineage specification of CD4+
T cells (Lehnertz et al., 2010). Our data indicate that in virus-spe-
cific CD8+ T cells, Blimp-1 recruits HDAC2 and G9a to critical
target genes that determine the fate of these T cells during the
contraction of the immune response. Although it remains
possible that Blimp-1 recruits additional chromatin-modifying
enzymes not examined in our studies, our data clearly demon-
strate that Blimp-1 plays a key role in regulating epigenetic
marks that impact the balance of short-lived effector versus
memory-precursor CD8+ T cells responding to acute virus
challenge.
EXPERIMENTAL PROCEDURES
Mice
Mice were bred and housed in specific pathogen-free conditions at the Univer-
sity of Massachusetts Medical School (UMMS) in accordance with the guide-
lines of the Institutional Animal Care and Use Committee of UMMS. OT-I TCR
transgenic Rag1/ mice were purchased from Taconic. WT C57BL/6
(CD90.2+CD45.2+) mice were purchased from Jackson Laboratories, and
CD4-Cre mice were a gift from Joonsoo Kang at UMMS. Prdm1/ miceamplicon2) ofCd27 (B). Data shown include a compilation of three independent
9a, aHDAC2, or rabbit IgG (isotype control [ISO]) antibodies. Secondary ChIP
a shown include a compilation of three independent experiments.
cells were isolated at day 7 postinfection. ChIP assays were performed with
CR for the indicated regions of Il2ra (D) andCd27 (E). Two permissive (H3Ac and
lysine 9 [H3K9me3], and trimethylated lysine 27 [H3K27me3]) modifications of
nt experiments.
4hiCD8+ T cells sorted at day 5 postinfection were analyzed by quantitative RT-
5 postinfection. ChIP assays were performed with antibodies to Blimp-1, G9a,
r direct comparison, ChIP assays were performedwith antibodies to Blimp-1 or
ch ChIP eluate was amplified by qPCR for the indicated regions of Il2ra (G) and
eriments, and error bars represent the SEM.
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cated, C57BL/6 CD4-Cre+ transgenic mice were used as WT controls. For
some experiments, P14+Prdm1fl/fl mice were crossed to Granzyme B-Cre+
transgenic mice for the deletion of Blimp-1 in activated CD8+ T cells, as previ-
ously described (Rutishauser et al., 2009).
T Cell Isolation and Adoptive Transfer
A total of 2 3 105 P14+CD45.1+ splenocytes were adoptively transferred into
CD45.2+ recipient mice, and infection with LCMV followed. At day 7 postinfec-
tion, total CD8+ T cells were isolated with the CD8+ T Cell Isolation Kit (Miltenyi
Biotec) and then CD25loP14+CD45.1+CD8+ or CD25hiP14+CD45.1+CD8+
T cells were further sorted on a FACSAria cell sorter. A total of 1 3 106 sorted
cells were adoptively transferred into infection-matched CD45.2+ congenic
WT mice. For CD27, 1 3 106 CD27loP14+CD45.1+CD8+ or CD27hiP14+
CD45.1+CD8+ T cells at day 9 postinfection were sorted on a FACSAria and
adoptively transferred into infection-matched CD45.2+ congenic WT mice.
Recipient mice were analyzed at day 8 posttransfer for CD25 or day 7 post-
transfer for CD27. The absolute numbers and percentages of P14+ cells
were determined by staining with a-CD8, a-CD44, and a-CD45.1 antibodies.
Proximity Ligation Assay and Confocal Microscopy
CD8+ T cells were cytospun onto positively-charged microscope slides
(Fisher, 12-550-20) and washed with cold PBS twice and were subsequently
fixed with 4% paraformaldehyde at 25C for 10 min. Fixed cells were washed
with PBS twice and permeabilized in PBS with 0.5% Triton X-100 at 4C for
6 min and were then washed with 70% ethanol. After samples were blocked
in the proximity ligation assay (PLA) blocking solution for 30 min at 37C,
they were incubated at 4C overnight with (1) aHDAC2 and either a mouse
immunoglobulin G (IgG) control or aBlimp-1 (1:100 dilution), (2) aG9a and a
mouse IgG control or aBlimp-1 (1:100 dilution), or (3) aEZH2 (1:100 dilution)
and a mouse IgG control or aBlimp-1 (1:100 dilution); the Duolink proximity
ligation assay was subsequently performed according to the manufacturer’s
instructions. Samples were counterstained for nuclei (blue; DAPI). The signals
(red) from each pair of PLA probes were detected with laser-scanning confocal
microscopy (Leica TCS SP5 II) with a 633 phase contrast oil immersion objec-
tive (numerical aperture = 1.3). The nuclei images were captured with the UV
laser. Duolink Detection kit 613 (LNK-90133-30), Duolink PLA probe Mouse
Plus (LNK-90701-30), and Duolink PLA probe Rabbit Minus (LNK-90602-30)
were purchased from Olink bioscience.
CFSE Labeling and In Vitro T Cell Stimulation
CD8+ T cells were isolated fromWTmice at days 5, 7, and 9 after LCMV infec-
tion or fromWT,Prdm1+/, orPrdm1/mice at day 7 postinfection. Cells were
labeled with CFSE as previously described (Shi et al., 2009) and were cultured
for 2 days with or without the indicated cytokines. IL-1b, IL-6, IL-12, IL-18,
IL-21, and IL-23 were purchased from R&D. IL-2 and IL-4 were purchased
from BD Biosciences. IFN-g, IL-7, and IL-15 were purchased from PeproTech.
IFN-b was purchased from PBL Interferon Source. Cytokine concentrations
were as follows: IFN-b (200 U), IFN-g (200 U), IL-1b (50 ng/ml), IL-2
(40 ng/ml), IL-4 (40 ng/ml), IL-6 (40 ng/ml), IL-7 (20 ng/ml), IL-12 (20 ng/ml),
IL-15 (20 ng/ml), IL-18 (20 ng/ml), IL-21 (20 ng/ml), and IL-23 (40 ng/ml).
Statistical Analysis
The statistical difference between samples was analyzed with an unpaired
Student’s t test. All error bars in this report represent the SEM.
ACCESSION NUMBERS
The Blimp-1 ChIP-seq data are available in the Gene Expression Omnibus
(GEO) database (http://www.ncbi.nlm.nih.gov/gds) under the accession num-
ber GSE48358.
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